Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.

Many adults with high LDL (bad) cholesterol resign themselves to taking a statin drug when no other lifestyle changes will work—and in most cases rightly so, since the evidence is strong for ...

The FDA has approved Zepbound, a weight-loss medication, as the first drug treatment for moderate to severe obstructive sleep ...

High Cholesterol Levels at a Young Age Significant ... Common Hair Loss and Prostate Drug May Also Cut Heart Disease Risk in Men and Mice Feb. 20, 2024 — The drug finasteride, also known as ...

FDA approves Zepbound for sleep apnoea, a weight-loss medication that improves OSA symptoms in obese patients.

Structures of ApoB100 show LDL receptor contact points ...

US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for ...

The Scottish Medicines Consortium (SMC) has rejected Daiichi Sankyo’s new cholesterol-lowering drug Nilemdo for use by NHS Scotland, saying the evidence backing the drug isn’t strong enough.

NPPA fixes retail prices for 65 new drug formulations and ceiling prices for 13, including vaccines and essential drugs.

US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for ...

The ceiling prices of seven other drugs were revised to include the impact of the 0.00551 per cent increase in drug prices in ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...